Dear CML Forum,
I am a new member and just now created my account.
My mother who is 75 years old, got diagnosed for CML in November 2020 in India where she lives and was commenced on Imatinib 400mg daily as her treatment.She has a background of hypothyroidism( takes 100mcg Eltroxin daily), chronic depression( takes Paroxetine 12.5mg) and difficulties with night time sleep( takes Zolpiderm 5mg daily).
Initially she responded well with her blood counts normalising within few weeks but by the 6 month, she developed gastrointestinal symptoms of frequent loose stools, nausea and crampy abdominal pain.These were initially managed with SOS use of Loperamide, Antispasmodics( Buscopan) or Tramadol if need be and taking daily Probiotics( Bifidobacterium), but gradually these were not helping too.
Her treating Haemato-Oncologist, then checked her BCR-ABL gene load which was still high( only 18% reduction) and ruled out any new mutations.Then treatment changed to Nilotinib( Tasigna) on the basis of intolerance to Imatinib and lack of expected molecular response.Unfortunately my mother couldnt tolerate Nilotinib within a week of starting it due to lot of body/back ache, tiredness, breathlessness and some abdominal pain with loose stools.
After 2 weeks of starting Nilotinib and developing above concerns, plan was made to retry Imatinib but at a lower dose of 300mg daily, see the response for a month or so and if no success then consider changing to a third TKI-Dasatinib.
The latest and current dilemma is that my mother had the same Imatinib side effects even on reducing dose to 300mg( mostly GI symptoms) and so after one week, she was changed to Dasatinib last week at a dose of 50mg daily.Unfortunately within 2 days of Dasatinib, she is experiencing lot of generalised body ache, weakness, headache and feels very miserable.Taking good doses of Paracetamol helps only slightly.
I feel as trapped in a big dilemma for how to manage the side effects in a satisfactory manner so as to allow compliance with treatment.
My questions are-
1 How much can we lower the doses for Imatinib( ? 200mg or less) or Dasatinib( ?25mg or less) or Nilotinib so as to minimise all above side effects and then be able to continue to take one of the medicines as long term?
2 For her elderly age and already being 75yrs old, is it necesary to keep a treatment target of deep molecular remission as this will warrant full doses of the respective medications and will not be easy?
3 Are there any better strategies to manage the side effects besides using Loperamide, anti-spasmodics/pain killers?
4 Is it common to see such side effects with all the 3 medicines mentioned or I need to consider some non CML reason( she possibly has some IBS), ? contribution from mental health issues?
What will happen if no TKI treatment is taken at all?Will she worsen to Accelerated phase of CML much earlier?
Will really appreciate some bright ideas and support please?Dr ST.